ICH tells drug makers how to cut cancer risk from mutagenic impurities
This article was originally published in SRA
Executive Summary
The International Conference on Harmonisation has finalized guidance to help drug makers identify, categorize and control impurities in drugs that can damage DNA and limit the potential for these impurities to cause cancer1,2.